A Study to Assess the Safety and Tolerabiliy of SR-878 in Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Interventions: Drug: SR-878 Sponsors: SciRhom GmbH; FGK Clinical Research GmbH Not yet recruiting
ClinicalTrials.gov
ClinicalTrials.gov
Category Added in a WPeMatico Campaign
ClinicalTrials.gov
Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARD
Conditions: Rheumatoid Arthritis Interventions: Drug: GenSci120 150 mg; Drug: GenSci120 600 mg; Drug: GenSci120 1000 mg; Drug: adalimumab injection 40
ClinicalTrials.gov
Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
Conditions: Inflammatory Arthritis; Diabetes (DM); Rheumatoid Arthritis (RA); Type 1 Diabetes Mellitus; Type 2 Diabetes (T2DM) Sponsors: Klavs Würgler Hansen
ClinicalTrials.gov
A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
Conditions: Systemic Lupus Erythematosus (SLE); Sjogren’s Syndrome (SS); Systemic Sclerosis (SSc); Inflammatory Myopathy; ANCA Associated Systemic Vasculitis Interventions: Biological: TI-0032-III
ClinicalTrials.gov
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid Interventions: Drug: BMS-986528 Sponsors: Bristol-Myers Squibb Not yet recruiting
ClinicalTrials.gov
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Conditions: Active Rheumatoid Arthritis Interventions: Drug: ELV001 25 mg; Drug: ELV001 75 mg; Drug: ELV001 125 mg; Drug: Placebo Sponsors:
ClinicalTrials.gov
Phase 3 Study of Telitacicept in Active Primary Sjögren’s Disease
Conditions: Primary Sjogren’s Disease Interventions: Biological: Telitacicept; Drug: Placebo Sponsors: Vor Biopharma Not yet recruiting
ClinicalTrials.gov
Study of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis (RA) Interventions: Drug: Group 1: TollB-001 100mg qd po; Group 2: TollB-001 200mg qd po; Group 3:
ClinicalTrials.gov
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Conditions: Refractory Lupus Nephritis; Myasthaenia Gravis; Stiff Person Syndrome; Rheumatoid Arthritis (RA); Multiple Sclerosis; Dermatomyositis; Systemic Sclerosis (SSc) Interventions: Drug:
ClinicalTrials.gov
Dysphagia in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis (RA Interventions: Diagnostic Test: flexible fiberoptic pharyngolaryngoscopy Sponsors: Tanta University Not yet recruiting
ClinicalTrials.gov
Evaluation of CCR6 Gene Expression and Circulating CCL20 Levels as Potential Biomarkers in Rheumatoid Arthritis
Conditions: Rhematoid Arthritis Interventions: Genetic: Gene expression by quantitative Real Time PCR Sponsors: Sohag University Not yet recruiting
ClinicalTrials.gov
Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
Conditions: Osteoarthitis; Arthritis Knee; Joint Diseases; Avascular Necrosis; Rheumatoid Arthritis of Knee Interventions: Device: EVOLUTION® NitrX™ Sponsors: MicroPort Orthopedics Inc.
ClinicalTrials.gov
Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)
Conditions: Rheumatoid Arthritis (RA); Systemic Sclerosis (SSc) Sponsors: Sohag University Not yet recruiting
ClinicalTrials.gov
Pharmacogenetics of Leflunomide in the Management of Rheumatoid Arthritis
Conditions: Rhematoid Arthritis Interventions: Drug: Study for the correlation of SNPs with efficacy and toxicity of Leflunomide in RA patients
ClinicalTrials.gov
Prognostic Factors and Predictors of Disease Flare in Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Disease Flare Interventions: Other: Clinical and Laboratory Monitoring for RA Disease Flare Sponsors: Sohag University Not yet
ClinicalTrials.gov
A Phase II Study of QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis (RA) Interventions: Drug: QLS12010; Drug: placebo Sponsors: Qilu Pharmaceutical Co., Ltd. Not yet recruiting
ClinicalTrials.gov
Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings
Conditions: Disease Activity Sponsors: Amera Imam Abdel – Ghany Ahmed Not yet recruiting
ClinicalTrials.gov
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Conditions: Systemic Lupus Erythematosus Interventions: Biological: GSK5926371 Sponsors: GlaxoSmithKline Not yet recruiting
ClinicalTrials.gov
Effect of Subthreshold Stimulation on Fatigue in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis (RA) Interventions: Device: Subthreshold stimulation; Other: Sham treatment Sponsors: Beni-Suef University Not yet recruiting
ClinicalTrials.gov
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Conditions: Systemic Lupus Erythematosus; Rheumatoid Arthritis Interventions: Biological: MK-1045 Sponsors: Merck Sharp & Dohme LLC Not yet recruiting
ClinicalTrials.gov
Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study
Conditions: Rheumatoid Arthritis; Atherosclerotic Ischemic Disease; Pulmonary Disease; Depressive Disorder; Anxiety Disorders; Cardiovascular and Respiratory Disease; Cardiovascular Biomarkers; Cardiovascular (CV)
ClinicalTrials.gov
The Effect of Cold Application in Patients With Rheumatoid Arthritis
Conditions: Cold Application; Pain; Disease Activity; Rheumatoid Arthritis (RA Interventions: Behavioral: Cold Application Sponsors: Saglik Bilimleri Universitesi Active, not recruiting
ClinicalTrials.gov
Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases
Conditions: Relapsed/Refractory Systemic Lupus Erythematosus; Relapsed/Refractory Systemic Sclerosis; Relapsed/Refractory Idiopathic Inflammatory Myopathies; Relapsed/Refractory sjögren’s Syndrome; Relapsed/Refractory Autoimmune Hemolytic Anemia; Relapsed/Refractory
ClinicalTrials.gov
Core Endurance, Finger Grip Strength, Fatigue, and Hand Function in Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis; Healthy Control Interventions: Other Sponsors: Cumhuriyet University Completed
ClinicalTrials.gov
Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis Interventions: Drug: Baricitinib Sponsors: Tanta University Not yet recruiting
ClinicalTrials.gov
Methotrexate Therapy and High-Resolution CT Chest and Spirometry Test Findings in Patients With Rheumatoid Arthritis.
Conditions: Methohexitone Pulmonary Adverse Reaction Sponsors: Ain Shams University Completed
ClinicalTrials.gov
Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis (RA) Interventions: Biological: A-319 Sponsors: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; ITabMed